| 000 | 01841 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516224742.0 | ||
| 264 | 0 | _c20150720 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1530-9932 | ||
| 024 | 7 |
_a10.1208/s12249-014-0176-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDu, Ju | |
| 245 | 0 | 0 |
_aSwellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery. _h[electronic resource] |
| 260 |
_bAAPS PharmSciTech _cDec 2014 |
||
| 300 |
_a1535-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 |
_aAlginates _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBronchoalveolar Lavage Fluid _xchemistry |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aChitosan _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCiprofloxacin _xadministration & dosage |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aGlucuronic Acid _xchemistry |
| 650 | 0 | 4 |
_aHexuronic Acids _xchemistry |
| 650 | 0 | 4 | _aHydrogels |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNanomedicine |
| 650 | 0 | 4 | _aNanoparticles |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 |
_aPolymers _xchemistry |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSurface Properties |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 700 | 1 | _aEl-Sherbiny, Ibrahim M | |
| 700 | 1 | _aSmyth, Hugh D | |
| 773 | 0 |
_tAAPS PharmSciTech _gvol. 15 _gno. 6 _gp. 1535-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1208/s12249-014-0176-x _zAvailable from publisher's website |
| 999 |
_c24058055 _d24058055 |
||